Duke Raleigh Hospital is a clinical research site located in Raleigh, North Carolina, United States 27609.
Crixeo Clinical Trials Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Duke Raleigh Hospital has participated in 50 clinical trials with 16 currently active.
Therapeutic areas: Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative.
Sponsors: National Cancer Institute (NCI), Gynecologic Oncology Group, SWOG Cancer Research Network.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Raleigh
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke Raleigh Hospital has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke Raleigh Hospital has 50 clinical trials on record, with 16 currently active. Their work covers Estrogen Receptor Positive, HER2 Positive Breast Carcinoma, HER2/Neu Negative.
Duke Raleigh Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.